U. Andersson

Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia

E. Widerlöv, U. Andersson, J. Häggström, 2004, Psychopharmacology.

GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias

U. Andersson, J. Häggström, 2004, Psychopharmacology.

Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia

E. Levin, U. Bondesson, L. Gunne, 1989, Movement disorders : official journal of the Movement Disorder Society.

Striatal binding of11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding

B. Långström, P. Hartvig, U. Andersson, 2005, Journal of Neural Transmission / General Section JNT.

Pharmacokinetics and effects on prolactin of remoxipride in patients with tardive dyskinesia

C. Bahr, E. Widerlöv, U. Andersson, 2005, Psychopharmacology.

Serum concentrations of thioridazine, its major metabolites and serum neuroleptic‐like activities in schizophrenics with and without tardive dyskinesia

C. Kilts, G. Breese, R. Mailman, 1982, Acta psychiatrica Scandinavica.

Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration

U. Bondesson, L. Gunne, U. Andersson, 1986, Pharmacology Biochemistry and Behavior.

Bromocriptine in Tardive Dyskinesia

L. Gunne, U. Andersson, J. Häggström, 1982, Pharmacopsychiatria.

Rhythmic jaw movements induced by ethanol in rats.

T. Lewander, L. Gunne, U. Andersson, 1989, Pharmacology & toxicology.